BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04895358-completion@plaintrial.com
DTSTAMP:20261028T011256Z
DTSTART;VALUE=DATE:20271218
SUMMARY:Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo P
 lus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic 
 Breast Cancer (MK-3475-B49/KEYNOTE-B49) — estimated completion date
DESCRIPTION:Active\, not recruiting. Saved on your PlainTrial shortlist. Fu
 ll trial record: https://plaintrial.com/trial/NCT04895358
URL:https://plaintrial.com/trial/NCT04895358
END:VEVENT
END:VCALENDAR